Heraeus Nexensos Supports Vaccine Cold-chain Logistics with Temperature Sensors: Company Is Increasing Production Capacity to Meet the Demand

Heraeus Nexensos advises providing a perfect cold chain for temperature-sensitive pharmaceutical products, such as vaccines and other biologicals, is a major logistical challenge for the pharmaceutical industry.  

Heraeus Nexensos platinum-based resistance temperature detectors (RTD) are a perfect fit for harsh cryogenic sensing applications. Heraeus RTD sensors provide reliable and accurate temperature measurement in dry ice (-78 °C), with capability down to -200 °C. Platinum RTDs exhibit extremely low drift, even after years of service, ensuring reliable data collection for the life of the measurement device. This reliability translates to precise monitoring of temperature-sensitive biochemical synthesis processes, and secure temperature control and monitoring for the complete cold chain logistic, from shipment to storage. 

“Heraeus sensors for cryogenic temperature measurement offer superior precision. More than 500 Million of delivered sensor elements have proven their reliability and outstanding performance in harsh environments. We are glad to support the efficacy and safety of cryo chains, especially for the logistics of vaccines against SARS-Cov-2.”, says Ralph Meschkat, President of Heraeus Nexensos. “We have already invested in 2020 in additional capacity and use this now to support increasing demand in this area. With our advanced planning system, we can now offer unmatched delivery times.” 

As the worldwide market and technology leader for platinum-based Resistance Temperature Sensors (RTD elements) Heraeus Nexensos offers its customers technical support in every major time zone in the world via application centers located in the US, China and Europe.  Sensor elements are available in tailormade sizes in support of various industrial applications. Nexensos’ production system and global inventories support short lead times and flexible supply arrangements.  

Platinum-based sensors are ideal for temperature measurement in challenging applications. The linear characteristics allow precise temperature sensing over the full measurement range. Applications include the monitoring of production process temperature stability, cryo-transport box temperature during transport, and ultra-low storage cooler temperature. Sensors are available for temperature measurement over a wide range from -200 to +1000 °C. Nexensos RTDs installed in harsh environments, such as automotive systems or power plants, exhibit a typical lifetime of 15 to 20 years.  

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy